SciSparc Finalizes Initial $2.0M Convertible Note Issuance at Significant Discount
SPRC is trading near its 52-week low of $0.53 (8.7% above the low).
Summary
SciSparc Ltd. finalized the issuance of an initial $2.0 million convertible promissory note for $1.8 million, representing a substantial and highly dilutive capital raise.
Key Events · Financing and Capital Events · SPRC
-
Initial Convertible Note Finalized
SciSparc Ltd. issued an initial convertible promissory note with a principal amount of $2.0 million to an institutional investor.
-
Discounted Purchase Price
The note was purchased for $1.8 million, reflecting a 10% discount to its principal value, representing a substantial portion of the company's market capitalization.
-
Payment Contingent on Resale Registration
The investor's obligation to pay the purchase price for the initial note is conditioned upon SciSparc filing a resale registration statement (Form F-3) covering the underlying shares and accompanying warrants.
-
Consulting Agreement Offset Option
The company may elect to offset amounts due under a consulting agreement with the investor against the purchase price payable for the initial or any additional notes.
Analysis · SPRC · Life Sciences
This 6-K provides definitive terms for the initial tranche of a previously announced convertible note financing, finalizing the issuance of a $2.0 million principal note for $1.8 million. This represents a substantial discount and is highly dilutive given the company's small market capitalization. The payment for this note is contingent on the filing of a resale registration statement, and the company may offset amounts due under a consulting agreement, indicating complex financing arrangements. This capital infusion is critical for the company's operations but comes at a high cost to existing shareholders, following a series of dilutive capital raises.
How filings like this one have moved
In the 30 days to Sep 12, 2026, 42.4% of the 495 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SPRC was trading at $0.58 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.5M. The 52-week trading range was $0.53 to $11.11. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.